Circadian Rhythmicity of Vital Signs at Intensive Care Unit Discharge and Outcome of Traumatic Brain Injury.


Journal

American journal of critical care : an official publication, American Association of Critical-Care Nurses
ISSN: 1937-710X
Titre abrégé: Am J Crit Care
Pays: United States
ID NLM: 9211547

Informations de publication

Date de publication:
01 11 2022
Historique:
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 3 11 2022
Statut: ppublish

Résumé

Physiological functions with circadian rhythmicity are often disrupted during illness. To assess the utility of circadian rhythmicity of vital signs in predicting outcome of traumatic brain injury (TBI). A retrospective single-center cohort study of adult intensive care unit (ICU) patients with largely isolated TBI to explore the relationship between the circadian rhythmicity of vital signs during the last 24 hours before ICU discharge and clinical markers of TBI severity and score on the Glasgow Outcome Scale 6 months after injury (GOS-6). The 130 study participants had a median age of 39.0 years (IQR, 23.0-59.0 years), a median Glasgow Coma Scale score at the scene of 8.0 (IQR, 3.0-13.0), and a median Rotterdam score on computed tomography of the head of 3 (IQR, 3-3), with 105 patients (80.8%) surviving to hospital discharge. Rhythmicity was present for heart rate (30.8% of patients), systolic blood pressure (26.2%), diastolic blood pressure (20.0%), and body temperature (26.9%). Independent predictors of a dichotomized GOS-6 ≥4 were the Rotterdam score (odds ratio [OR], 0.38 [95% CI, 0.18-0.81]; P = .01), Glasgow Coma Scale score at the scene (OR, 1.22 [95% CI, 1.05-1.41]; P = .008), age (OR, 0.95 [95% CI, 0.92-0.98]; P = .003), oxygen saturation <90% in the first 24 hours (OR, 0.19 [95% CI, 0.05-0.73]; P = .02), serum sodium level <130 mmol/L (OR, 0.20 [95% CI, 0.05-0.70]; P = .01), and active intracranial pressure management (OR, 0.16 [95% CI, 0.04-0.62]; P = .008), but not rhythmicity of any vital sign. Circadian rhythmicity of vital signs at ICU discharge is not predictive of GOS-6 in patients with TBI.

Sections du résumé

BACKGROUND
Physiological functions with circadian rhythmicity are often disrupted during illness.
OBJECTIVE
To assess the utility of circadian rhythmicity of vital signs in predicting outcome of traumatic brain injury (TBI).
METHODS
A retrospective single-center cohort study of adult intensive care unit (ICU) patients with largely isolated TBI to explore the relationship between the circadian rhythmicity of vital signs during the last 24 hours before ICU discharge and clinical markers of TBI severity and score on the Glasgow Outcome Scale 6 months after injury (GOS-6).
RESULTS
The 130 study participants had a median age of 39.0 years (IQR, 23.0-59.0 years), a median Glasgow Coma Scale score at the scene of 8.0 (IQR, 3.0-13.0), and a median Rotterdam score on computed tomography of the head of 3 (IQR, 3-3), with 105 patients (80.8%) surviving to hospital discharge. Rhythmicity was present for heart rate (30.8% of patients), systolic blood pressure (26.2%), diastolic blood pressure (20.0%), and body temperature (26.9%). Independent predictors of a dichotomized GOS-6 ≥4 were the Rotterdam score (odds ratio [OR], 0.38 [95% CI, 0.18-0.81]; P = .01), Glasgow Coma Scale score at the scene (OR, 1.22 [95% CI, 1.05-1.41]; P = .008), age (OR, 0.95 [95% CI, 0.92-0.98]; P = .003), oxygen saturation <90% in the first 24 hours (OR, 0.19 [95% CI, 0.05-0.73]; P = .02), serum sodium level <130 mmol/L (OR, 0.20 [95% CI, 0.05-0.70]; P = .01), and active intracranial pressure management (OR, 0.16 [95% CI, 0.04-0.62]; P = .008), but not rhythmicity of any vital sign.
CONCLUSION
Circadian rhythmicity of vital signs at ICU discharge is not predictive of GOS-6 in patients with TBI.

Identifiants

pubmed: 36316179
pii: 31880
doi: 10.4037/ajcc2022821
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

472-482

Informations de copyright

©2022 American Association of Critical-Care Nurses.

Auteurs

Rob Boots (R)

Rob Boots is an associate professor, Thoracic Medicine, Royal Brisbane and Women's Hospital, a senior specialist, Intensive Care, Bundaberg Hospital, Faculty of Medicine, The University of Queensland, Herston, and a professsor, Faculty of Medicine and Dentistry, Griffith University, Queensland, Australia.

George Xue (G)

George Xue is the medical registrar, Royal Brisbane and Women's Hospital.

Dirk Tromp (D)

Dirk Tromp is the senior radiology registrar, Royal Brisbane and Women's Hospital.

Oliver Rawashdeh (O)

Oliver Rawashdeh is director, Chronobiology and Sleep Research, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland.

Judith Bellapart (J)

Judith Bellapart is a senior specialist, Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, and Burns, Trauma, and Critical Care, The University of Queensland.

Shane Townsend (S)

Shane Townsend is director, Intensive Care Services, Royal Brisbane and Women's Hospital.

Michael Rudd (M)

Michael Rudd is acting director, Trauma, Royal Brisbane and Women's Hospital.

Craig Winter (C)

Craig Winter is a staff specialist neurosurgeon, Royal Brisbane and Women's Hospital.

Gary Mitchell (G)

Gary Mitchell is a staff specialist, Emergency Medicine, Royal Brisbane and Women's Hospital.

Nicholas Garner (N)

Nicholas Garner is a PhD student, Chronobiology and Sleep Research Lab, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland.

Pierre Clement (P)

Pierre Clement is a clinical information systems manager, Intensive Care Services, Royal Brisbane and Women's Hospital.

Nermin Karamujic (N)

Nermin Karamujic is a data manager and clinical information systems manager, Intensive Care Services, Royal Brisbane and Women's Hospital.

Christopher Zappala (C)

Christopher Zappala is a senior staff specialist, Thoracic Medicine, Royal Brisbane and Women's Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH